Treatment

MIT researchers discuss the process of creating glucose-sensing insulin and whether if it will ever be available for people with diabetes.

A mobile health CEO believes Apple fell short in creating a device that could have revolutionized diabetes self-care.

Here’s what we’ve gleaned about the smartwatch’s capabilities to help with Type 1 diabetes self-care.

People with Type 1 can electronically sign up for the T1D Exchange Living BioBank to be considered for future studies.

The device delivers unreliable vital signs in certain conditions.

There have been poor launch sales of the new inhalable insulin system. Can it rebound?

Regulators are requiring all multi-dose pens be labeled “For single patient use only”.

A personal trainer with Type 1 suggests a plan to treat lows in a healthier manner than a fridge raid.

Diabetes educator Jennifer Smith answers a question about cutting-edge pump technology.

The insulin automatically stabilized high blood-sugar in mice with diabetes.

A study suggests that a severe lack of bacteria in stomachs of toddlers could signal a future Type 1 diagnosis.

Microcapsules inserted beneath the skin of mice slowly released insulin after being exposed to micro-shockwaves.

A pump user discovers her relationship with her pump requires much the same attention as a romantic relationship.

We get a glimpse into the marketing strategy for Afrezza.

People with diabetes spend $2,790 a year more to stay healthy than they those with diabetes did 20 years ago.

In this Quick Hit article, we share new research on brain cells that control lows.

Tattoo CGMs, Afrezza news, Dexcom profits, Medtronic’s merger.

Insulin Nation's editor suggests a way for the FDA to allow individuals to create better CGMs and insulin pumps.

The Insulin Nation Treatment Roundup - late January 2015